Patient care is provided primarily at MedStar Georgetown University Hospital, through a clinical partnership with MedStar Health. MedStar Georgetown is the area’s most recognized academic teaching hospital. MedStar Health is one of the largest, most geographically diverse, integrated healthcare delivery networks in the area. Many physicians at MedStar Georgetown are School of Medicine faculty members — responsible for teaching the next generation of clinicians.
Georgetown University’s Lombardi Comprehensive Cancer Center at Georgetown University Medical Center is designated by the National Cancer Institute (NCI) as a comprehensive cancer center — the only cancer center in the Washington, D.C., area to hold this distinction. Cancer care at Georgetown Lombardi is delivered through our clinical partners at MedStar Health.
Through this clinical partnership, Georgetown Lombardi serves as the research engine of a regional program — the MedStar Georgetown Cancer Institute — extending the cancer center’s reach throughout the Washington/Baltimore area. The MedStar Georgetown Cancer Institute integrates Georgetown Lombardi’s research into cancer prevention, treatment, rehabilitation and survivorship with clinical care, primarily at MedStar Georgetown University Hospital and MedStar Washington Hospital Center, but also across the network of hospitals and ambulatory centers in the MedStar Health system. As a result, patients have greater access to clinical trials, advanced clinical cancer care and state-of-the-art technologies at more convenient locations.
Clinical trials are research studies that test new drugs or combinations of drugs, treatments, or medical procedures to determine their safety and effectiveness. Through these studies, clinicians aim to understand how to better provide personalized medical treatment to each patient.